Objectives:
The Global Lipid Consortium aims to advance research and innovation in the realm of lipids for mRNA-based applications, with a specific emphasis on the synthesis and physico-chemical characterization of new lipids for use in the development of mRNA-based vaccines and therapeutics. The key objectives of the Consortium are as follows:
- Foster the exchange of scientific knowledge pertaining to the discovery and development of novel lipids.
- Deliberate on product development pathways for mRNA-based applications, focusing particularly on innovative lipid formulations.
- Explore the design of research studies to enhance understanding of novel lipids, including considerations such as stability, bio-availability, targeting, and bio-degradability. Evaluate the implications of these factors on the safety, immunogenicity, and efficacy of mRNA-based products.
- Discuss and propose novel manufacturing processes for mRNA-LNP formulations to optimize production efficiency.
- Develop normative documents, including a Target Product Profile, to provide guidance and expedite the development of mRNA-based vaccines, incorporating insights into novel lipid applications.
- Conduct assessments to determine whether the novel lipid structures under investigation within the consortium are already covered by intellectual property held by organizations not affiliated with the consortium.
Registration
Registration for this event is currently open.
